Company intelligence / Profile preview

Mabo-Farma

Alcalá de Henares, Madrid, Spainmabofarma.com ↗

Ownership: Private
Employees: ~60
Development stage: Other

Overview

Mabo-Farma is an established Spanish pharmaceutical company focused on the commercialization of generic drugs, with a portfolio exceeding 200 SKUs. The majority of its revenue comes from prescription medicines, but it is also expanding into consumer healthcare and OTC products. The company was acquired by PharmaS Group in 2023 to strengthen their presence in Spain and Western Europe.

Modalities: Small molecule
Industry: Biotech

Partnerships

PharmaS Group

Beyond the preview

Go deeper on Mabo-Farma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mabo-Farma.

Explore the full profile